Symbols / MNMD
MNMD Chart
About
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.46B |
| Enterprise Value | 1.31B | Income | -168.10M | Sales | — |
| Book/sh | 1.70 | Cash/sh | 2.12 | Dividend Yield | — |
| Payout | 0.00% | Employees | 74 | IPO | — |
| P/E | — | Forward P/E | -8.47 | PEG | — |
| P/S | — | P/B | 8.83 | P/C | — |
| EV/EBITDA | -8.65 | EV/Sales | — | Quick Ratio | 3.20 |
| Current Ratio | 3.30 | Debt/Eq | 31.38 | LT Debt/Eq | — |
| EPS (ttm) | -1.98 | EPS next Y | -1.77 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-05 | ROA | -33.95% |
| ROE | -85.59% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 97.22M |
| Shs Float | 97.56M | Short Float | 15.37% | Short Ratio | 7.82 |
| Short Interest | — | 52W High | 18.12 | 52W Low | 4.70 |
| Beta | 2.62 | Avg Volume | 2.12M | Volume | 2.04M |
| Target Price | $28.67 | Recom | Strong_buy | Prev Close | $14.87 |
| Price | $15.02 | Change | 1.01% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$28.67
Mean price target
2. Current target
$15.02
Latest analyst target
3. DCF / Fair value
$-8.83
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.02
Low
$16.00
High
$61.00
Mean
$28.67
- Mind Medicine (MNMD) Stock Analysis: Exploring the 99.75% Potential Upside in the Biotech Sector - DirectorsTalk Interviews Fri, 24 Oct 2025 07
- MindMed (MNMD): Evaluating Valuation After Recent Share Price Momentum Cools - Yahoo Finance Sun, 09 Nov 2025 08
- If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - The Motley Fool ue, 12 Aug 2025 07
- $MNMD stock is down 10% today. Here's what we see in our data. - Quiver Quantitative Mon, 03 Nov 2025 08
- Brain health biotech anticipates 3 Phase 3 readouts after JP Morgan talk - Stock Titan hu, 18 Dec 2025 08
- Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq Mon, 21 Jul 2025 07
- MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Zacks Investment Research Mon, 29 Dec 2025 08
- Wall Street Thinks This 1 Psychedelic Stock Can Gain 335% in 2026 - Barchart.com hu, 25 Dec 2025 08
- Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st Sat, 09 Aug 2025 07
- Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week - Yahoo Finance ue, 30 Sep 2025 07
- Mind Medicine (MNMD) Stock Analysis: 95% Potential Upside Draws Investor Attention - DirectorsTalk Interviews Fri, 03 Oct 2025 07
- 1 Reason to Buy MindMed (MNMD) - The Motley Fool hu, 07 Aug 2025 07
- $MNMD stock is up 14% today. Here's what we see in our data. - Quiver Quantitative Mon, 21 Jul 2025 07
- Mind Medicine (MNMD) Price Target Increased by 11.49% to 29.15 - Nasdaq Wed, 14 Jan 2026 08
- Brain Health Biotech MindMed Awards 182,800 Stock Options as Hiring Inducements - Stock Titan Mon, 22 Sep 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 11276 | 148244 | — | Sale at price 13.15 per share. | SULLIVAN MARK R | Officer | — | 2025-12-26 00:00:00 | D |
| 1 | 25791 | 339072 | — | Sale at price 13.15 per share. | BARROW ROBERT B | Chief Executive Officer | — | 2025-12-26 00:00:00 | D |
| 2 | 5600 | 73623 | — | Sale at price 13.15 per share. | KARLIN DANIEL ROLLINGS | Officer | — | 2025-12-26 00:00:00 | D |
| 3 | 11278 | 110186 | — | Sale at price 9.77 per share. | SULLIVAN MARK R | Officer | — | 2025-09-25 00:00:00 | D |
| 4 | 25797 | 252037 | — | Sale at price 9.77 per share. | BARROW ROBERT B | Chief Executive Officer | — | 2025-09-25 00:00:00 | D |
| 5 | 7704 | 75268 | — | Sale at price 9.77 per share. | KARLIN DANIEL ROLLINGS | Officer | — | 2025-09-25 00:00:00 | D |
| 6 | 11491 | 78139 | — | Sale at price 6.80 per share. | SULLIVAN MARK R | Officer | — | 2025-06-25 00:00:00 | D |
| 7 | 26491 | 180139 | — | Sale at price 6.80 per share. | BARROW ROBERT B | Chief Executive Officer | — | 2025-06-25 00:00:00 | D |
| 8 | 7848 | 53366 | — | Sale at price 6.80 per share. | KARLIN DANIEL ROLLINGS | Officer | — | 2025-06-25 00:00:00 | D |
| 9 | 6576 | 44322 | — | Sale at price 6.74 per share. | SULLIVAN MARK R | Officer | — | 2025-03-25 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | -1.06K |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.01 |
| NormalizedEBITDA | -91.83M | -85.17M | -71.19M | -91.15M |
| TotalUnusualItems | -14.04M | -6.48M | 8.04M | -86.00K |
| TotalUnusualItemsExcludingGoodwill | -14.04M | -6.48M | 8.04M | -86.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -108.68M | -95.73M | -56.80M | -93.04M |
| ReconciledDepreciation | 527.00K | 3.16M | 3.18M | 2.62M |
| EBITDA | -105.87M | -91.65M | -63.15M | -91.24M |
| EBIT | -106.40M | -94.81M | -66.33M | -93.85M |
| NetInterestIncome | 9.28M | 4.66M | 1.50M | -359.00K |
| InterestExpense | 2.28M | 920.00K | 359.00K | |
| InterestIncome | 11.56M | 5.58M | ||
| NormalizedIncome | -94.64M | -89.25M | -64.83M | -92.95M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -108.68M | -95.73M | -56.80M | -93.04M |
| TotalExpenses | 103.92M | 93.87M | 66.33M | 93.85M |
| TotalOperatingIncomeAsReported | -103.92M | -93.87M | -66.33M | -93.85M |
| DilutedAverageShares | 70.46M | 39.16M | 30.86M | 27.38M |
| BasicAverageShares | 70.46M | 39.16M | 30.86M | 27.38M |
| DilutedEPS | -1.54 | -2.44 | -1.84 | -3.45 |
| BasicEPS | -1.54 | -2.44 | -1.84 | -3.45 |
| DilutedNIAvailtoComStockholders | -108.68M | -95.73M | -56.80M | -93.04M |
| NetIncomeCommonStockholders | -108.68M | -95.73M | -56.80M | -93.04M |
| NetIncome | -108.68M | -95.73M | -56.80M | -93.04M |
| NetIncomeIncludingNoncontrollingInterests | -108.68M | -95.73M | -56.80M | -93.04M |
| NetIncomeContinuousOperations | -108.68M | -95.73M | -56.80M | -93.04M |
| TaxProvision | 0.00 | -1.16M | ||
| PretaxIncome | -108.68M | -95.73M | -56.80M | -94.19M |
| OtherIncomeExpense | -14.04M | -6.53M | 8.04M | 20.00K |
| OtherNonOperatingIncomeExpenses | -51.00K | 2.00K | 106.00K | |
| SpecialIncomeCharges | 2.54M | 0.00 | ||
| OtherSpecialCharges | -2.54M | |||
| GainOnSaleOfSecurity | -16.58M | -6.48M | 8.04M | -86.00K |
| NetNonOperatingInterestIncomeExpense | 9.28M | 4.66M | 1.50M | -359.00K |
| TotalOtherFinanceCost | -4.66M | -1.50M | 359.00K | |
| InterestExpenseNonOperating | 2.28M | 920.00K | 359.00K | |
| InterestIncomeNonOperating | 11.56M | 5.58M | ||
| OperatingIncome | -103.92M | -93.87M | -66.33M | -93.85M |
| OperatingExpense | 103.92M | 93.87M | 66.33M | 93.85M |
| ResearchAndDevelopment | 65.30M | 52.12M | 36.17M | 34.79M |
| SellingGeneralAndAdministration | 38.62M | 41.74M | 30.16M | 59.06M |
| GeneralAndAdministrativeExpense | 38.62M | 41.74M | 30.16M | 59.06M |
| OtherGandA | 38.62M | 41.74M | 30.16M | 59.06M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 75.10M | 41.10M | 37.98M | 28.10M |
| ShareIssued | 75.10M | 41.10M | 37.98M | 28.10M |
| TotalDebt | 21.85M | 14.13M | 72.00K | 0.00 |
| TangibleBookValue | 221.53M | 57.69M | 127.31M | 124.88M |
| InvestedCapital | 263.30M | 92.26M | 150.92M | 151.66M |
| WorkingCapital | 242.77M | 71.63M | 128.16M | 126.81M |
| NetTangibleAssets | 221.53M | 57.69M | 127.31M | 124.88M |
| CapitalLeaseObligations | 72.00K | 0.00 | ||
| CommonStockEquity | 241.45M | 78.13M | 150.92M | 151.66M |
| TotalCapitalization | 263.30M | 92.26M | 150.92M | 151.66M |
| TotalEquityGrossMinorityInterest | 241.45M | 78.13M | 150.92M | 151.66M |
| StockholdersEquity | 241.45M | 78.13M | 150.92M | 151.66M |
| GainsLossesNotAffectingRetainedEarnings | 819.00K | 343.00K | 627.00K | 1.05M |
| OtherEquityAdjustments | 819.00K | 343.00K | 627.00K | 1.05M |
| RetainedEarnings | -398.88M | -290.20M | -194.47M | -137.67M |
| AdditionalPaidInCapital | 639.51M | 367.99M | 344.76M | 288.29M |
| CapitalStock | 0.00 | 0.00 | 0.00 | 0.00 |
| CommonStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 60.70M | 46.41M | 19.08M | 12.34M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 21.85M | 14.16M | 1.18M | 1.93M |
| OtherNonCurrentLiabilities | 32.00K | 1.18M | 1.93M | |
| TradeandOtherPayablesNonCurrent | 1.93M | |||
| LongTermDebtAndCapitalLeaseObligation | 21.85M | 14.13M | ||
| LongTermDebt | 21.85M | 14.13M | ||
| CurrentLiabilities | 38.85M | 32.25M | 17.89M | 10.41M |
| OtherCurrentLiabilities | 24.01M | 16.48M | 9.90M | |
| CurrentDebtAndCapitalLeaseObligation | 72.00K | |||
| CurrentCapitalLeaseObligation | 72.00K | 0.00 | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 6.41M | 4.53M | 3.20M | 2.29M |
| PayablesAndAccruedExpenses | 8.43M | 11.24M | 4.79M | 8.11M |
| CurrentAccruedExpenses | 6.42M | 4.27M | 1.11M | 3.22M |
| Payables | 2.01M | 6.98M | 3.68M | 4.89M |
| OtherPayable | 2.84M | 1.57M | 716.00K | |
| AccountsPayable | 2.01M | 4.14M | 2.11M | 4.18M |
| TotalAssets | 302.15M | 124.54M | 169.99M | 164.00M |
| TotalNonCurrentAssets | 20.53M | 20.67M | 23.94M | 26.79M |
| OtherNonCurrentAssets | 613.00K | 224.00K | 331.00K | |
| GoodwillAndOtherIntangibleAssets | 19.92M | 20.45M | 23.61M | 26.79M |
| OtherIntangibleAssets | 527.00K | 3.69M | 6.87M | |
| Goodwill | 19.92M | 19.92M | 19.92M | 19.92M |
| CurrentAssets | 281.62M | 103.87M | 146.06M | 137.22M |
| OtherCurrentAssets | 7.88M | 4.17M | 3.91M | 3.68M |
| PrepaidAssets | 3.91M | 3.68M | ||
| CashCashEquivalentsAndShortTermInvestments | 273.74M | 99.70M | 142.14M | 133.54M |
| CashAndCashEquivalents | 273.74M | 99.70M | 142.14M | 133.54M |
| CashFinancial | 133.54M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -79.13M | -64.36M | -50.14M | -45.82M |
| RepaymentOfDebt | -128.00K | -844.00K | 0.00 | |
| IssuanceOfDebt | 10.98M | 22.53M | 0.00 | |
| IssuanceOfCapitalStock | 250.00M | 0.00 | 42.30M | 81.92M |
| InterestPaidSupplementalData | 2.22M | 534.00K | 0.00 | |
| EndCashPosition | 273.74M | 99.70M | 142.14M | 133.54M |
| BeginningCashPosition | 99.70M | 142.14M | 133.54M | 80.09M |
| EffectOfExchangeRateChanges | -30.00K | 79.00K | -309.00K | 742.00K |
| ChangesInCash | 174.07M | -42.52M | 8.91M | 52.70M |
| FinancingCashFlow | 253.20M | 21.85M | 59.05M | 98.82M |
| CashFlowFromContinuingFinancingActivities | 253.20M | 21.85M | 59.05M | 98.82M |
| NetOtherFinancingCharges | -8.38M | 114.00K | -1.91M | |
| ProceedsFromStockOptionExercised | 716.00K | 49.00K | 18.66M | 16.90M |
| NetCommonStockIssuance | 250.00M | 0.00 | 42.30M | 81.92M |
| CommonStockIssuance | 250.00M | 0.00 | 42.30M | 81.92M |
| NetIssuancePaymentsOfDebt | 10.86M | 21.68M | 0.00 | |
| NetLongTermDebtIssuance | 10.86M | 21.68M | 0.00 | |
| LongTermDebtPayments | -128.00K | -844.00K | 0.00 | |
| LongTermDebtIssuance | 10.98M | 22.53M | 0.00 | |
| InvestingCashFlow | 0.00 | -297.00K | ||
| CashFlowFromContinuingInvestingActivities | 0.00 | -297.00K | ||
| NetBusinessPurchaseAndSale | 0.00 | -297.00K | ||
| PurchaseOfBusiness | 0.00 | -297.00K | ||
| OperatingCashFlow | -79.13M | -64.36M | -50.14M | -45.82M |
| CashFlowFromContinuingOperatingActivities | -79.13M | -64.36M | -50.14M | -45.82M |
| ChangeInWorkingCapital | -3.34M | 6.28M | -3.78M | 1.88M |
| ChangeInOtherWorkingCapital | -180.00K | -1.16M | ||
| ChangeInOtherCurrentLiabilities | -32.00K | -1.15M | -870.00K | |
| ChangeInOtherCurrentAssets | 48.00K | 51.00K | -180.00K | |
| ChangeInPayablesAndAccruedExpense | 977.00K | 7.34M | -2.47M | 5.20M |
| ChangeInAccruedExpense | 3.10M | 5.32M | -416.00K | 4.63M |
| ChangeInPayable | -2.13M | 2.02M | -2.06M | 569.00K |
| ChangeInAccountPayable | -2.13M | 2.02M | -2.06M | 1.28M |
| ChangeInPrepaidAssets | -4.34M | 39.00K | -260.00K | -2.16M |
| OtherNonCashItems | -993.00K | 468.00K | 43.00K | |
| StockBasedCompensation | 16.91M | 15.18M | 13.71M | 42.72M |
| DepreciationAmortizationDepletion | 527.00K | 3.16M | 3.18M | 2.62M |
| DepreciationAndAmortization | 527.00K | 3.16M | 3.18M | 2.62M |
| AmortizationCashFlow | 527.00K | 3.16M | 3.18M | 2.62M |
| AmortizationOfIntangibles | 527.00K | 3.16M | 3.18M | 2.62M |
| OperatingGainsLosses | 16.45M | 6.27M | -6.49M | |
| GainLossOnInvestmentSecurities | 15.94M | 6.64M | -6.34M | |
| NetForeignCurrencyExchangeGainLoss | 506.00K | -363.00K | -148.00K | 0.00 |
| NetIncomeFromContinuingOperations | -108.68M | -95.73M | -56.80M | -93.04M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MNMD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|